TIDMRGT 
 
ReGen's ColostrininTM Approved for Marketing in Turkey 
 
<AIM: RGT> 
 
04/05/2010 
 
ReGen Therapeutics Plc ('ReGen' or the 'Company') announces that its Turkish 
licensee Eczacibasi Ilac Pazarlama A.S ('Eczacibasi')1 has received final 
approval to market ReGen's nutritional supplement Colostrinin(TM) in the 
Republic of Turkey. 
 
This approval now triggers a $50,000 milestone payment to ReGen. Eczacibasi has 
placed an order with ReGen for a launch stock of blistered tablets for which 
ReGen will receive a fee for the active ingredient component. These will be 
packaged locally by Eczacibasi under the brand-name 'Dyna' with product launch 
intended in May. Net Revenues to ReGen from Eczacibasi pursuant to the minimum 
annual purchase commitments in the distribution agreement are estimated to be 
$52,000 in the first year after final approval is obtained, and $104,000 in the 
second year. No further details of the launch will be disclosed at this time. 
 
This announcement comes only a week after ReGen reported that Colostrinin(TM) is 
expected to be launched in India during the second quarter of 2010.  Launch in 
these markets are key targets for ReGen as it seeks to achieve sustainable 
profitability in 2010. 
 
Colostrinin(TM)  is marketed as a nutritional supplement to 'support healthy 
brain ageing and cognition in humans'. To date the product is marketed in the 
US, Canada and Australia under the brand name CogniSure(TM) 2 , in Cyprus3  and 
Poland 4 under the brand name Cognase(TM)  and in the UK5 under the brand name 
MemoryAid. 
 
1 Eczacibasiwww.eczacibasi.com <http://www.eczacibasi.com/>  is a leading 
turkish industrials group with 40 companies, approximately 9,300 employees and 
revenues of $3.2bn in 2007. Eczacibasi's Ilac Pazarlama A.S. division is based 
in Levent-Istanbul, Turkey. 
 
2 Colostrinin(TM) for use as a human nutraceutical is licensed in North America 
and Australasia to Metagenics Inc. of San Clemente, Californiawww.metagenics.com 
<http://www.metagenics.com/>). 
 
3 Colostrinin(TM) is distributed in the Republic of Cyprus by Golgi 
Pharmaceuticals Ltd (www.healthybrainaging.com 
<http://www.healthybrainaging.com/>) 
 
4 Colostrinin(TM) is is distributed in Poland by Tagerr Polska an affliate of 
Tagerr a professional services and trading company established in Köln, Germany. 
(www.cognisure.eu <http://www.cognisure.eu/>) 
 
5 Colostrinin(TM) is distributed in the UK by PRG Nutraceuticals Ltd 
(www.memoryaid.com <http://www.memoryaid.com/>) 
 
For further information, please contact: 
 
Percy Lomax 
ReGen Therapeutics Plc 
Tel: 020 7153 4920 
 
Roland Cornish/Felicity Geidt 
Beaumont Cornish Limited 
Tel: 020 7628 3396 
 
David Scott/Nick Bealer 
Alexander David Securities Limited 
Tel: 020 7448 9820 
 
 
 
 
 
 
. 
 
 
[HUG#1411109] 
 

Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Argent Biopharma Charts.
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Argent Biopharma Charts.